A California-based company is seeking US Food and Drug Administration (FDA) authorisation to market what it calls the first “vapour-style inhalable” nicotine replacement therapy (NRT) device
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields